These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1337466)

  • 1. Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKK.
    Hürny C; Bernhard J; Joss R; Willems Y; Cavalli F; Kiser J; Brunner K; Favre S; Alberto P; Glaus A
    Ann Oncol; 1992 Dec; 3(10):825-31. PubMed ID: 1337466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Fatigue and malaise" as a quality-of-life indicator in small-cell lung cancer patients. The Swiss Group for Clinical Cancer Research (SAKK).
    Hürny C; Bernhard J; Joss R; Schatzmann E; Cavalli F; Brunner K; Alberto P; Senn HJ; Metzger U
    Support Care Cancer; 1993 Nov; 1(6):316-20. PubMed ID: 8156249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK).
    Bernhard J; Hürny C; Bacchi M; Joss RA; Cavalli F; Senn HJ; Leyvraz S; Stahel R; Ludwig C; Alberto P
    Br J Cancer; 1996 Nov; 74(10):1660-7. PubMed ID: 8932352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-life assessment in cancer clinical trials: an intervention by itself?
    Bernhard J; Gusset H; Hürny C
    Support Care Cancer; 1995 Jan; 3(1):66-71. PubMed ID: 7697305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA; Alberto P; Hürny C; Bacchi M; Leyvraz S; Thürlimann B; Cerny T; Martinelli G; Stahel R; Ludwig C
    Ann Oncol; 1995 Jan; 6(1):41-8. PubMed ID: 7536028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA; Bacchi M; Hürny C; Bernhard J; Cerny T; Martinelli G; Leyvraz S; Senn HJ; Stahel R; Siegenthaler P
    Ann Oncol; 1995 Feb; 6(2):157-66. PubMed ID: 7786823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of the Administration of quality of life (QL) questionnaires in three multicentre randomised trials in cancer. The Medical Research Council Lung Cancer Working Party the CHART Steering Committee.
    Hopwood P; Harvey A; Davies J; Stephens RJ; Girling DJ; Gibson D; Parmar MK
    Eur J Cancer; 1998 Jan; 34(1):49-57. PubMed ID: 9624237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Machin D; Stephens RJ
    Br J Cancer; 1993 Dec; 68(6):1157-66. PubMed ID: 7505104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK).
    Bernhard J; Hürny C; Maibach R; Herrmann R; Laffer U
    Ann Oncol; 1999 Jul; 10(7):775-82. PubMed ID: 10470423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial.
    Geddes DM; Dones L; Hill E; Law K; Harper PG; Spiro SG; Tobias JS; Souhami RL
    Eur J Cancer; 1990 Apr; 26(4):484-92. PubMed ID: 2162692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.
    Thatcher N; Qian W; Clark PI; Hopwood P; Sambrook RJ; Owens R; Stephens RJ; Girling DJ
    J Clin Oncol; 2005 Nov; 23(33):8371-9. PubMed ID: 16293867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
    Paccagnella A; Favaretto A; Oniga F; Barbieri F; Ceresoli G; Torri W; Villa E; Verusio C; Cetto GL; Santo A; De Pangher V; Artioli F; Cacciani GC; Parodi G; Soresi F; Ghi MG; Morabito A; Biason R; Giusto M; Mosconi P; Chiarion Sileni V;
    Lung Cancer; 2004 Jan; 43(1):83-91. PubMed ID: 14698542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.
    Pujol JL; Daurès JP; Rivière A; Quoix E; Westeel V; Quantin X; Breton JL; Lemarié E; Poudenx M; Milleron B; Moro D; Debieuvre D; Le Chevalier T
    J Natl Cancer Inst; 2001 Feb; 93(4):300-8. PubMed ID: 11181777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined-modality treatment of small-cell lung cancer: randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA; Alberto P; Bleher EA; Ludwig C; Siegenthaler P; Martinelli G; Sauter C; Schatzmann E; Senn HJ
    Ann Oncol; 1994 Dec; 5(10):921-8. PubMed ID: 7696164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile.
    Bergman B; Sullivan M; Sörenson S
    Acta Oncol; 1992; 31(1):19-28. PubMed ID: 1316770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life assessment in chemotherapy trials for non-small cell lung cancer: are theory and practice significantly different?
    Hopwood P
    Semin Oncol; 1996 Oct; 23(5 Suppl 10):60-4. PubMed ID: 8893884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of 'quality of life' using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer.
    Gower NH; Rudd RM; Ruiz de Elvira MC; Spiro SG; James LE; Harper PG; Souhami RL
    Ann Oncol; 1995 Jul; 6(6):575-80. PubMed ID: 8573537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer.
    Hickish TF; Smith IE; Nicolson MC; Ashley S; Priest K; Spencer L; Norman A; Middleton G; O'Brien ME
    Br J Cancer; 1998 Jun; 77(11):1966-70. PubMed ID: 9667676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party.
    Br J Cancer; 1996 Feb; 73(3):406-13. PubMed ID: 8562352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
    van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
    Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.